Nephrodite, Inc., a medical device company developing an implantable, continuous renal replacement system, today announced ...

A Travere Therapeutics drug for a rare disease that can progress to kidney failure has converted its status to full FDA approval, strengthening the product’s case to compete against two other ...

The US Food and Drug Administration has approved the ultrasound-based Paradise renal denervation system for the treatment of hypertension, marking the culmination of more than a decade of work—with ...

Brian Connor, 20, received a kidney from his identical twin brother last year. — -- A 20-year-old college student who got a kidney donated by his identical twin brother is reaping a rare benefit ...

A Novartis drug candidate for a rare kidney disease has preliminary data from a pivotal study suggesting it could be competitive with two available treatments, and the pharmaceutical giant is now ...

In a drug-wide association study, several unlikely drug candidates exhibited safety signals with respect to AKI. A drug-wide association study identified 16 medications associated with acute kidney ...

The University of Wisconsin transplant team recently collaborated with the UW National Primate Research Center and the UW Veterinary Hospital to pursue a novel kidney transplant procedure involving ...

At present, around 59 million adults worldwide have diabetes, about 64 million are diagnosed with heart failure, and ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows. Not only is ...